As Patients With DMD Live Longer, Treatment of Cardiac Dysfunction Is More Urgent
We investigate the importance of cardiac care in DMD patients and explore how it has improved over the last few years.
We investigate the importance of cardiac care in DMD patients and explore how it has improved over the last few years.
We examine the lasting impact of innovative clinical trial designs for rare diseases on other clinical experiments.
Is genome editing ready for widespread use among DMD patients around the globe? We explore this question in detail.
We investigate how CRISPR/Cas technology is contributing to genetic studies and its impact on DMD research.
We still do not have a primary cure for DMD, so what strategies are available for improving patient care?
Researchers investigated the promise and the pitfalls of gene therapy in DMD patient care and explored whether it has a viable future.
We investigate the genetic correction strategies available for DMD patients today and assess their impact on the heart.
We explore the current standard management options for DMD, and contemplate what future therapies will be able to accomplish.
Why do some Duchenne muscular dystrophy clinical trials end in termination? Researchers identified 5 key reasons.
Genetic approaches that target the affected muscle cells in DMD and restore the disrupted reading frame of the dystrophin gene have curative potential.